| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.02 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.11 | 0.02 |